Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gentien

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
EMBO Molecular Medicine|January 10, 2013
The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signallingCristovão Moreira Sousa, John Russel McGuire, Morgane Sonia Thion, et al.
Oncotarget|March 19, 2016
The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanomaNabil Amirouchene-Angelozzi, Estelle Frisch-Dit-Leitz, Guillaume Carita, et al.
Bioinformatics (Oxford, England)|July 14, 2014
Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing dataValentina Boeva, Tatiana Popova, Maxime Lienard, et al.
Journal of Medical Genetics|September 1, 2010
Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcomaFranck Bourdeaut, Aurélie Hérault, David Gentien, et al.
International Journal of Cancer|April 21, 2015
Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinomaOumou Goundiam, Pierre Gestraud, Tatiana Popova, et al.
Carcinogenesis|January 30, 2013
Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomasLuis Jaime Castro-Vega, Karina Jouravleva, Win-Yan Liu, et al.
Molecular Cancer Therapeutics|May 20, 2016
Chromatin Regulators as a Guide for Cancer Treatment ChoiceZachary A Gurard-Levin, Laurence O W Wilson, Vera Pancaldi, et al.
The Journal of Pathology|January 25, 2023
Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesisJacqueline Fontugne, Jennifer Wong, Luc Cabel, et al.
Nucleic Acids Research|October 16, 2018
Genome-wide identification of genic and intergenic neuronal DNA regions bound by Tau protein under physiological and stress conditionsHouda Benhelli-Mokrani, Zeyni Mansuroglu, Alban Chauderlier, et al.
Genome Research|February 6, 2015
The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancerRonan Chaligné, Tatiana Popova, Marco-Antonio Mendoza-Parra, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
EMBO Molecular Medicine|January 10, 2013
The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signallingCristovão Moreira Sousa, John Russel McGuire, Morgane Sonia Thion, et al.
Oncotarget|March 19, 2016
The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanomaNabil Amirouchene-Angelozzi, Estelle Frisch-Dit-Leitz, Guillaume Carita, et al.
Bioinformatics (Oxford, England)|July 14, 2014
Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing dataValentina Boeva, Tatiana Popova, Maxime Lienard, et al.
Journal of Medical Genetics|September 1, 2010
Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcomaFranck Bourdeaut, Aurélie Hérault, David Gentien, et al.
International Journal of Cancer|April 21, 2015
Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinomaOumou Goundiam, Pierre Gestraud, Tatiana Popova, et al.
Carcinogenesis|January 30, 2013
Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomasLuis Jaime Castro-Vega, Karina Jouravleva, Win-Yan Liu, et al.
Molecular Cancer Therapeutics|May 20, 2016
Chromatin Regulators as a Guide for Cancer Treatment ChoiceZachary A Gurard-Levin, Laurence O W Wilson, Vera Pancaldi, et al.
The Journal of Pathology|January 25, 2023
Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesisJacqueline Fontugne, Jennifer Wong, Luc Cabel, et al.
Nucleic Acids Research|October 16, 2018
Genome-wide identification of genic and intergenic neuronal DNA regions bound by Tau protein under physiological and stress conditionsHouda Benhelli-Mokrani, Zeyni Mansuroglu, Alban Chauderlier, et al.
Genome Research|February 6, 2015
The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancerRonan Chaligné, Tatiana Popova, Marco-Antonio Mendoza-Parra, et al.
Pageof 9